Eurofins Scientific SE provided revenue guidance for the fiscal year 2024. For the year, the company expects revenue including M&A of 7,250 million.
Real-time
Other stock markets
|
5-day change | 1st Jan Change | ||
55.44 EUR | -1.32% | -7.38% | -5.97% |
13/05 | Eurofins Scientific to Expand US Battery Materials Testing Capabilities | MT |
13/05 | Eurofins Scientific expands capacity in the USA | CF |
EPS Revisions
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-5.97% | 11.78B | |
+17.73% | 83.46B | |
-2.68% | 25.66B | |
+3.21% | 17.91B | |
-13.68% | 16.54B | |
+0.75% | 15.43B | |
+74.92% | 13.46B | |
+73.16% | 12.78B | |
+37.14% | 12.6B | |
+2.08% | 12.55B |
- Stock Market
- Equities
- ERF Stock
- News Eurofins Scientific SE
- Eurofins Scientific SE Provides Revenue Guidance for the Fiscal Year 2024